Callidus Software (CALD) 19.21 $CALD CallidusCloud Wins

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Callidus Software (CALD) 19.21 $CALD

CallidusCloud Wins Big at Prestigious Awards Programs
Marketwire Canada - Tue Aug 30, 7:00AM CDT
Lead to Money Turns to Gold at International Business Awards and Tops the Medal Table at Best in Biz Awards
CALD: 19.21 (-0.11)

Citrix (CTXS) Brings NetScaler CPX's Free Developer Version
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 8:11AM CDT
Citrix Systems, Inc. (CTXS) recently announced the release of NetScaler CPX Express to cater to the high demand for application development.
AVID: 9.04 (+0.05), AZPN: 45.62 (+0.16), CALD: 19.21 (-0.11), CTXS: 87.28 (+0.08)

SAP Reveals Plans to Foray into China with SAP Ariba
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 7:51AM CDT
SAP SE (SAP) recently announced its plans to venture into the Chinese market by making its well-reputed business to business network, Ariba, available in the country by the end of 2016.
SAP: 88.47 (+0.50), AZPN: 45.62 (+0.16), CALD: 19.21 (-0.11), DST: 121.67 (+0.16)

SAP Collaborates with Vivanda for FlavorPrint Technology
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 6:56AM CDT
SAP SE (SAP) recently collaborated with data-driven culinary management platform Vivanda to utilize the latter's FlavorPrint technology for its customers.
SAP: 88.47 (+0.50), AZPN: 45.62 (+0.16), CALD: 19.21 (-0.11), DST: 121.67 (+0.16)

Microsoft Bundles Productivity Apps with Lenovo Devices
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:15AM CDT
Microsoft Corporation (MSFT) has added Lenovo to the list of companies with which it has patent cross-licensing deals.
MSFT: 57.59 (+0.13), CALD: 19.21 (-0.11), DST: 121.67 (+0.16), DWCH: 6.95 (unch)

CallidusCloud Named a Top 20 Company to Sell For
Marketwire Canada - Tue Aug 23, 7:01AM CDT
CallidusCloud Earns a Top Spot on Selling Power's '50 Best Companies to Sell For' List
CALD: 19.21 (-0.11)

FinancialForce.com Selects CallidusCloud Commissions and Territory and Quota
Marketwire Canada - Tue Aug 09, 7:00AM CDT
DUBLIN, CA--(Marketwired - Aug 9, 2016) - Callidus Software Inc. (NASDAQ: CALD), a global leader in cloud-based sales, marketing, learning and customer experience solutions, announced today that FinancialForce.com, a leading cloud ERP provider, has selected CallidusCloud Commissions and Territory and Quota.
CALD: 19.21 (-0.11)

CallidusCloud Announces Conference Attendance and Presentations
Marketwire Canada - Mon Aug 08, 8:15AM CDT
DUBLIN, CA--(Marketwired - Aug 8, 2016) - Callidus Software Inc. (NASDAQ: CALD), a global leader in cloud-based sales, marketing, learning and customer experience solutions, today announced that CallidusCloud Management will be presenting at the following investor conferences. A webcast of the company's presentations will be available on the "Investor Relations" section of the company's website at: http://www.calliduscloud.com/about-us/investor-relations/.
CALD: 19.21 (-0.11)

Downgrade Alert for Callidus Software (CALD)
Comtex SmarTrend(R) - Thu Aug 04, 3:11AM CDT
Callidus Software (NASDAQ:CALD) was downgraded from Buy to Neutral at Dougherty today. The stock closed yesterday at $18.61 on volume of 3.8 million shares, above average daily volume of 605,000. Callidus Software delivers enterprise application software called business performance systems. The Company's Enterprise Incentive Management (EIM) software system allows enterprises to model, administer, analyze and report pay-for-performance plans, which are designed to align employee, sales, and channel tactics with targeted business objectives.
CALD: 19.21 (-0.11)

Callidus Software Up 24.6% Since SmarTrend Uptrend Call (CALD)
Comtex SmarTrend(R) - Thu Aug 04, 12:48AM CDT
SmarTrend identified an Uptrend for Callidus Software (NASDAQ:CALD) on March 18th, 2016 at $14.94. In approximately 5 months, Callidus Software has returned 24.56% as of today's recent price of $18.61.
CALD: 19.21 (-0.11)

Watch for Callidus Software to Potentially Rebound After Falling 12.41% Yesterday
Comtex SmarTrend(R) - Wed Aug 03, 2:42PM CDT
Callidus Software (NASDAQ:CALD) traded in a range yesterday that spanned from a low of $17.25 to a high of $17.89. Yesterday, the shares fell 12.4%, which took the trading range below the 3-day low of $19.70 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CALD: 19.21 (-0.11)

Vodafone Germany Selects CallidusCloud Commissions
Marketwired - Wed Aug 03, 10:00AM CDT
DUBLIN, CA--(Marketwired - Aug 3, 2016) - Callidus Software Inc. (NASDAQ: CALD), a global leader in cloud-based sales, marketing, learning and customer experience solutions, announced today that Vodafone Germany, one of the nation's leading integrated telecommunications company, has selected CallidusCloud Commissions for their new sales commissioning software solution. Vodafone Germany joins more than 70 of the world's leading telcos on the number one commissions cloud in the industry.
CALD: 19.21 (-0.11), VOD: 30.19 (-0.46)

CallidusCloud Announces Second Quarter SaaS Revenue Increases 33% to $36.2 Million
Marketwire Canada - Tue Aug 02, 3:05PM CDT
DUBLIN, CA--(Marketwired - Aug 2, 2016) - Callidus Software Inc. (NASDAQ: CALD)
CALD: 19.21 (-0.11)

Notable Tuesday Option Activity: CALD, CSTE, RIGL
DividendChannel.com - Tue Aug 02, 2:31PM CDT
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Callidus Software Inc , where a total volume of 3,779 contracts has been traded thus far today, a contract volume which is...
CALD: 19.21 (-0.11)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 431

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Brixton Metals Delivers Promising Drill Results in Thorn Project

Updated Category News Views 167

Brixton Metals' Latest Drill Results Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) recently unveiled its second batch of drill results from the 2025 exploration season. The company operates the Thorn Project, an underexplored district known for its potential in copper-gold porphyry deposits. Highlighting Impressive Assay Results The recent drilling at the...

Continue Reading
US Labor Market Stagnation: A Closer Look at 2025 Trends

Updated Category News Views 275

November Layoffs and Hiring Trends In November, layoffs by U.S. employers reduced significantly, signaling a shift in the job market dynamics. Yet, companies are still hesitant to recruit new employees, indicating a labor market that remains restrained due to various pressures. Businesses are facing challenges such as soft demand, tariff implications, and soaring...

Continue Reading
Dollar Steady Amid Global Market Uncertainty and Yuan Weakness

Updated Category News Views 127

Asian Currency Markets React to U.S. Dollar Strength In the bustling arena of Asian currencies, the atmosphere is charged with anticipation as investors monitor the situation in China regarding potential economic stimulus measures. Meanwhile, the U.S. dollar is exhibiting remarkable strength, currently hovering near a two-and-a-half month high. This rise comes in light of...

Continue Reading
Understanding Recent Insider Trades at Omega Healthcare Invts

Updated Category News Views 75

Examining Insider Trades at Omega Healthcare Invts Recently, a notable insider trade involving Omega Healthcare Invts has drawn attention. Chief Operating Officer Daniel Booth executed a significant transaction, selling 56,725 shares as disclosed through an SEC filing. This particular sale took place on a recent date and revealed a total transaction value of $2,283,181....

Continue Reading
Exploring Future Growth in Healthcare Digital Payments Market

Updated Category News Views 150

Introduction to Digital Payments in Healthcare The transformation in the realm of healthcare is not just about treatments and services; it extends deeply into how payments are managed. The Digital Payment in Healthcare Market is evolving, with an anticipated growth in value reaching USD 61,521.8 Million by the year 2033. This incredible increase is projected to occur at a...

Continue Reading